bromodeoxyuridine has been researched along with Atypical Lipomatous Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batarseh, A; Campioli, E; Li, J; Papadopoulos, V | 1 |
| Adams, JM; Boddie, AW; Roth, JA; Winters, WD | 1 |
2 other study(ies) available for bromodeoxyuridine and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
The endocrine disruptor mono-(2-ethylhexyl) phthalate affects the differentiation of human liposarcoma cells (SW 872).
Topics: 3T3-L1 Cells; Adipocytes; Animals; Biomarkers; Bromodeoxyuridine; Cell Differentiation; Cell Line, Tumor; Diethylhexyl Phthalate; Endocrine Disruptors; Gene Knockdown Techniques; Humans; Liposarcoma; Mice; Peroxisome Proliferator-Activated Receptors; Protein Kinase C-epsilon; Receptors, GABA; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic | 2011 |
Biological activation of virus-like particles from chemically induced Guinea pig sarcomas.
Topics: Adenoviridae; Animals; Antibody Formation; Bromodeoxyuridine; Cells, Cultured; Concanavalin A; Culture Media; Female; Fibrosarcoma; Guinea Pigs; Immunodiffusion; Inclusion Bodies, Viral; Injections, Subcutaneous; Liposarcoma; Methylcholanthrene; Osteosarcoma; Sarcoma, Experimental; Thymidine; Tritium | 1975 |